Navigation Links
Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/25/2011

6.7.7 SMC 021 94

6.7.8 Ostora 94

6.7.9 BA058- injection 96

6.7.10 UNI-PH (1-34), rhPTH 1-34 96

6.7.11 YM529 / ONO-5920 --- Astellas/ ONO 97

6.8 Key Takeaway 97

7 Osteoporosis Therapeutics: Clinical Trials Mapping 98

7.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 98

7.2 Clinical Trials by Phase of Clinical Development 99

7.3 Clinical Trials by Trial Status 100

7.4 Prominent Sponsors 101

7.5 Clinical Trials by Sponsors 102

7.6 Top Companies Participating in Osteoporosis Therapeutics Clinical Trials 103

8 Osteoporosis Therapeutics: Strategic Assessment 105

8.1 Key Events Impacting the Future Market 105

8.2 Future Market Competition Scenario 105

9 Osteoporosis Therapeutics: Future Players 108

9.1 Introduction 108

9.2 Company Profiles 108

9.2.1 Amgen Inc. 108

9.2.2 Astellas Pharma, Inc. 111

9.2.3 EffRx, Inc. 113

9.2.4 Merck & Co., Inc. 114

9.2.5 Novartis AG 115

9.2.6 Osteologix, Inc. 117

9.2.7 Pfizer Inc. 118

9.2.8 Radius Health, Inc 122

9.2.9 Tarsa Inc. 123

9.2.10 Zyduscadila Inc. 123

9.3 Other Companies in the Osteoporosis Therapeutics Market 126

9.4 Key Takeaway 129

10 Osteoporosis Therapeutics: Licensing & Partnership Deals 129

11 Osteoporosis Therapeutics: Appendix 140

11.1 Market Definitions 140

11.2 Abbreviations 140

11.3 Research Methodology 142

11.3.1 Coverage 142

11.3.2 Secondary Research 142

11.3.3 Forecasting 143

11.3.4 Primary Research 145

11.3.5 Expert Panel Validation 146

11.4 Contact Us 146

11.5 Disclaimer 146

11.6 Bibliography 147

List of Tables

Table 1: Difference Between Type I and Type II Osteoporosis 19

Table 2: Osteoporosis Prevalence and Low Bone Mass in People Aged 50 and Over (The US) (million
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Zosano Pharma, Inc. and Asahi Kasei Pharma Corporation Enter Exclusive Licensing Agreement for a Weekly Transdermal Patch Formulation of Teribone™ (teriparatide acetate) for Osteoporosis
2. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
3. Tarsa Therapeutics Presents Positive Efficacy and Safety Data Comparing Its Oral Calcitonin to Nasal Calcitonin and Placebo in Phase III Osteoporosis Treatment Trial
4. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
5. Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Delivery of BA058 for Treatment of Osteoporosis
6. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
7. Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
8. ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination
9. Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease
10. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
11. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 Merck (NYSE: ... and Canada , is teaming with ... La Diabetes: Logra Tus Metas , an educational program encouraging Hispanics ... sugar -- a key treatment goal to help reduce the risk ... are at a higher risk for developing type 2 ...
(Date:9/19/2014)... Sept. 19, 2014 UBM Medica US announces ... online community to help oncologists and other clinicians gain ... the use of targeted therapies and immunotherapies, discusses some ... treatment.  Every September, Blood Cancer ... raise awareness about blood cancers—helping to increase survival rates ...
(Date:9/19/2014)... 19, 2014 According to ... (Benchtop, Mobile, Industrial, & Laboratory), Industry (Food, Pharmaceutical, ... & Rotary) & Geography - Global Trends & ... segments the lyophilization market on the basis of ... projections of the market size of each of ...
Breaking Medicine Technology:Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3
... Pharmacy Technician Certification Board (PTCB) launches the ... pharmacy profession on recommended changes to the PTCB ... pharmacy technician exams and additional requirements for PTCB ... practical experience, criminal background checks, and completion of ...
... 1, 2012 A consistent theme within healthcare ... innovation and disease treatment is progression.  An example ... in healthcare IT, which is expected to become ... healthcare industry.  Companies must maintain a vantage point ...
Cached Medicine Technology:PTCB Calls For Profession-wide Feedback on Proposed Changes to Certification Program 2Frost & Sullivan's Global Healthcare Approach Evolves to Contend with Today's Challenges 2Frost & Sullivan's Global Healthcare Approach Evolves to Contend with Today's Challenges 3
(Date:9/22/2014)... (PRWEB) September 22, 2014 TherapySites ... titled "From Divorce Talk to Solution Talk: Solution Focused ... The 60-minute webinar, presented by special guest speaker Elliott ... 1pm Central Standard Time. , Reserve Your Seat ... Solution Talk: Solution Focused Brief Therapy with the Most ...
(Date:9/22/2014)... The Ruby Report was launched by ... International Conference in Louisville, Kentucky. This release followed the ... a reception attended by 60 people from the local ... had gained while conducting her research, what drove her ... issue, and what she believes companies can do to ...
(Date:9/21/2014)... CA (PRWEB) September 22, 2014 CareSpan ... it has entered into a joint services agreement with ... Dakota, to deploy the CareSpan Virtual Clinic in multiple ... Avera eCARE plan to deploy their joint services in ... and Wyoming where Avera eCARE is licensed. The two ...
(Date:9/21/2014)... September 22, 2014 UNIWIGS, one of the ... extensions and hair pieces, offers a line of human hair ... trend and it also shows people what the latest ... famous star Rihanna, there are 4 different hairstyles to choose ... of ombre wave lace wigs and a hot ombre red ...
(Date:9/21/2014)... September 21, 2014 More than a quarter of ... dryer fires start in one of two ways. The first ... out properly. The second type of dryer fire occurs when ... (Dryers can also catch fire due to malfunctioning electrical systems so ... to take a look!) Here are some ways that you ...
Breaking Medicine News(10 mins):Health News:TherapySites Presents a Webinar, "From Divorce Talk to Solution Talk: Solution Focused Brief Therapy with the Most Trying of Couples Sessions” with Elliott Connie 2Health News:TherapySites Presents a Webinar, "From Divorce Talk to Solution Talk: Solution Focused Brief Therapy with the Most Trying of Couples Sessions” with Elliott Connie 3Health News:Ruby Report Book Launch Reveals Critical Insights on Gender Intelligence 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 3Health News:UniWigs New Arrivals Just In- Human Hair Lace Wigs Inspired By Famous Celebrities 2Health News:Restoration Local Offers Tips to Avoid Dryer Fires 2Health News:Restoration Local Offers Tips to Avoid Dryer Fires 3
... and more than 300 people in the UK die from ... permanent disabilities. Now researchers will work on a potential vaccine ... medical charity Meningitis UK. , Although vaccines exist to protect ... to protect against all strains, including the most common in ...
... Immediate Moratorium on Bisphenol,A in Baby Bottles, Food and ... Dozens of state,and national environmental health organizations in the ... the use of bisphenol A (BPA) in baby,bottles and ... of a,new study that demonstrates the toxic chemical BPA ...
... intramuscular injection, study says , , THURSDAY, Feb. 7 ... for delivering DNA vaccines than intramuscular injection, a new ... Genetic Vaccines and Therapy , researchers at the ... protein from the human papillomavirus (HPV), which causes cervical ...
... operating results for the fourth quarter and year ended December 31,2007., Fourth ... $6.883 billion. -- Net income totaled $278 million, ... prior year. -- Adjusted EBITDA totaled $1.153 ... in the prior year. -- Provision for doubtful ...
... DURHAM, NC A novel drug designed to lessen muscle ... at the Duke Clinical Research Institute. Results of the study, ... issue of the journal Circulation, reflect the first time the ... known as KAI-9803, blocks the activity of an enzyme called ...
... 7 Anthera Pharmaceuticals,Inc., a privately held biopharmaceutical ... the Phase II trial,of its novel secretory phospholipaseA2 ... disease will be presented as a late breaker,at ... Scientific Session,on Monday, March 31, 2008 in Chicago, ...
Cached Medicine News:Health News:Meningitis vaccine study gets £200,000 boost 2Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 2Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 3Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 4Health News:Tattooing Best Way to Deliver DNA Vaccines 2Health News:HCA Reports Fourth Quarter - Year End 2007 Results 2Health News:HCA Reports Fourth Quarter - Year End 2007 Results 3Health News:HCA Reports Fourth Quarter - Year End 2007 Results 4Health News:HCA Reports Fourth Quarter - Year End 2007 Results 5Health News:HCA Reports Fourth Quarter - Year End 2007 Results 6Health News:HCA Reports Fourth Quarter - Year End 2007 Results 7Health News:HCA Reports Fourth Quarter - Year End 2007 Results 8Health News:HCA Reports Fourth Quarter - Year End 2007 Results 9Health News:HCA Reports Fourth Quarter - Year End 2007 Results 10Health News:HCA Reports Fourth Quarter - Year End 2007 Results 11Health News:HCA Reports Fourth Quarter - Year End 2007 Results 12Health News:HCA Reports Fourth Quarter - Year End 2007 Results 13Health News:HCA Reports Fourth Quarter - Year End 2007 Results 14Health News:HCA Reports Fourth Quarter - Year End 2007 Results 15Health News:Novel compound may lessen heart attack damage 2Health News:Data From Anthera's Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: